Biological and Psychological Influences of Cross-Sex Hormone in Transgender

Cross-Sex Hormones in Transgender

Hatta Sidi. Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603 91456143/+603 91456142 Email: hattasidi@hotmail.com

Anderson, R.A., Bancroft, J., Wu, F. 1992. The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab 75(6): 1503-7. Asscheman, H., Giltay, E.J., Megens, J.A., de Ronde, W.P., van Trotsenburg, M.A., Gooren, L.J. 2011. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164(4): 635-42. American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). American Psychiatric Pub. Aultman, B. 2014. Cisgender. Transgender Studies Quarterly 1(1-2): 61-2. Baucom, D.H., Besch, P.K., Callahan, S. 1985. Relation between testosterone concentration, sex role identity, and personality among females. J Pers Soc Psychol 48(5): 1218-26. Berenbaum, S.A., Beltz, A.M. 2011. Sexual differentiation of human behavior: effects of prenatal and pubertal organizational hormones. Front Neuroendocrinol 32(2): 183-200. Budge, S.L., Adelson, J.L., Howard, K.A. 2013. Anxiety and depression in transgender individuals: the roles of transition status, loss, social support, and coping. J Consult Clin Psychol 81(3): 545-57. Cavanaugh, T. 2016. Cross-sex hormone therapy. In Proceedings of the First Advancing Excellence In Transgender Health Conference: Boston, MA. The Fenway Institute. Chakrapani, V., Lakshmi, P., Tsai, A.C., Vijin, P.P., Kumar, P., Srinivas, V. 2019. The syndemic of violence victimisation, drug use, frequent alcohol use, and hiv transmission risk behaviour among men who have sex with men: cross-sectional, population-based study in India. SSM-Popul Health 3: 7. Clements-Nolle, K., Marx, R., Katz, M. 2006. Attempted suicide among transgender persons: the influence of gender-based discrimination and victimization. J Homosex 51(3): 53-69. Cohen-Kettenis, P.T., Gooren, L.J. 1999. Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res 46(4): 315-3. Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., Decuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W.J. 2012. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend 13(4): 165-232. Colizzi, M., Costa, R., Todarello, O. 2014. Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study. Psychoneuroendocrinology 39: 65-73. Colton Meier, S.L., Fitzgerald, K.M., Pardo, S.T., Babcock, J. 2011. The effects of hormonal gender affirmation treatment on mental health in female-to-male transsexuals. J Gay Lesbian Ment Health 15(3): 281-99. Conron, K.J., Scott, G., Stowell, G.S., Landers, S.J. 2012. Transgender health in massachusetts: results from a household probability sample of adults. Am J Public Health 102(1): 118-22. De Cuypere, G., Van Hemelrijck, M., Michel, A., Carael, B., Heylens, G., Rubens, R., Hoebeke, P., Monstrey, S. 2007. Prevalence and demography of transsexualism in Belgium. Eur Psychiatry 22(3): 137-41. Dessens, A.B., Cohen-Kettenis, P.T., Mellenbergh, G.J., vd Poll, N., Koppe, J.G., Boer, K. 1999. Prenatal exposure to anticonvulsants and psychosexual development. Arch Sex Behav 28(1): 31-44. Elias, A., Kumar, A. 2007. Testosterone for schizophrenia. Cochrane Database of Syst Rev 18(3): CD006197. Evardone, M., Alexander, G.M., Morey, L.C. 2008. Hormones and Borderline Personality Features. Pers Individ Dif 44(1): 278-87. Gardner, I.H., Safer, J.D. 2013. Progress on the road to better medical care for transgender patients. Curr Opin Endocrinol Diabetes Obes 20(6): 553-8. Gómez-Gil, E., Trilla, A., Salamero, M., Godás, T., Valdés, M. 2009. Sociodemographic, clinical, and psychiatric characteristics of transsexuals from spain. Arch Sex Behav 38(3): 378-92. Gonzales, G., Henning-Smith, C. 2017. Barriers to care among transgender and gender nonconforming adults. Milbank Q 95(4): 726-48. Gooren, L.J., Kreukels, B., Lapauw, B., Giltay, E.J. 2015. (Patho)physiology of cross-sex hormone administration to transsexual people: the potential impact of male–female genetic differences. Andrologia 47(1): 5-19. Gorin-Lazard, A., Baumstarck, K., Boyer, L., Maquigneau, A., Gebleux, S., Penochet, J. C., Pringuey, D., Albarel, F., Morange, I., Loundou, A., Berbis, J. 2012. Is hormonal therapy associated with better quality of life in transsexuals? a cross-sectional study. J Sex Med 9(2): 531-41. Hall, J.E. 2015. Guyton and Hall Textbook of Medical Physiology E-Book. Elsevier Health Sciences. Hatta, S., Sharifah Ezat, W.P., Marhani, M., Norni, A. 2007. Female sexual dysfunction among malaysian women in a primary care setting: does the frequency of sexual activity matter? Med Health 2(1): 48-57. Hoffman, B. 2014. An overview of depression among transgender women. Depress Res Treat 2014 Articel ID 394283 Irwig, M.S. 2017. Testosterone therapy for transgender men. Lancet Diabetes Endocrinol 5(4): 301-11. James, S., Herman, J., Rankin, S., Keisling, M., Mottet, L., Ana, M. 2017. The Report of the 2015 US Transgender Survey. 2016. Washington, DC, The National Center for Transgender Equality. Keo-Meier, C.L., Herman, L.I., Reisner, S.L., Pardo, S.T., Sharp, C., Babcock, J.C. 2015. Testosterone treatment and MMPI–2 improvement in transgender men: a prospective controlled study. J Consult Clin Psychol 83(1): 143-56. Khobzi Rotondi, N. 2012. Depression in trans people: a review of the risk factors. Int J Transgend 13(3): 104-16. Kirkbride, J.B., Errazuriz, A., Croudace, T.J., Morgan, C., Jackson, D., Boydell, J., Murray, R. M., Jones, P.B. 2012. Incidence of schizophrenia and other psychoses in england, 1950–2009: a systematic review and meta-Analyses. PloS One 7(3): e31660. Levine, S.B. 2009. Real-life test experience: recommendations for revisions to the standards of care of the world professional association for transgender health. Int J Transgend 11(3): 186-93. Mc Ewen, B.S. 2001. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 91(6): 2785-801. Mohammadi, M.R., Khaleghi, A. 2018. Transsexualism: a different viewpoint to brain changes. Clin Psychopharmacol Neurosci 16(2): 136-43. Moore, E., Wisniewski, A., Dobs, A. 2003. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88(8): 3467-73. Mueller, S.C., Landré, L., Wierckx, K., T’sjoen, G. 2017. A structural magnetic resonance imaging study in transgender persons on cross-sex hormone therapy. Neuroendocrinology 105(2): 123-30. Nguyen, H.B., Loughead, J., Lipner, E., Hantsoo, L., Kornfield, S.L., Epperson, C.N. 2018. What has sex got to do with it? the role of hormones in the transgender brain. Neuropsychopharmacology 44(1): 22-37. O’connor, D.B., Archer, J., Hair, W.M., Wu, F.C. 2002. Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men. Physiol Behav 75(4): 557-66. Prince, V. 2005. Sex vs. Gender. Int J Transgend 8(4): 29-32. Rhoades, R., Tanner, G. 2003. Medical Physiology 2nd Edition. Lippincott Williams & Wilkins 343(372-374). Savic, I., Garcia-Falgueras, A., Swaab, D.F. 2010. Sexual differentiation of the human brain in relation to gender identity and sexual orientation. Prog Brain Res 186: 41-62. Seiger, R., Hahn, A., Hummer, A., Kranz, G.S., Ganger, S., Woletz, M., Kraus, C., Sladky, R., Kautzky, A., Kasper, S., Windischberger, C., Lanzenberger, R. 2016. Subcortical gray matter changes in transgender subjects after long-term cross-sex hormone administration. Psychoneuroendocrinology 74: 371-9. Slabbekoorn, D., Van Goozen, S.H., Megens, J., Gooren, L.J., Cohen-Kettenis, P.T. 1999. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology 24(4): 423-47. Spizzirri, G., Duran, F.L.S., Chaim-Avancini, T.M., Serpa, M.H., Cavallet, M., Pereira, C.M.A., Santos, P.P., Squarzoni, P., da Costa, N.A., Busatto, G.F., Abdo, C.H.N. 2018. Grey and white matter volumes either in treatment-naïve or hormone-treated transgender women: a voxel-based morphometry study. Sci Rep 8(1): 736. Swaab, D.F., Fliers, E. 1985. A sexually dimorphic nucleus in the human brain. Science 228(4703): 1112-5. Swaab, D.F. 2004. Sexual differentiation of the human brain: relevance for gender identity, transsexualism and sexual orientation. Gynecol Endocrinol 19(6): 301-12. Tee, B.C., Ahmad Rasidi, M.S., Mohd Rushdan, M.N., Ismail, A., Sidi, H. 2014. The prevalence and risk factors of sexual dysfunction in gynaecological cancer patients. Med Health 9(1): 53-61. Trotman, H.D., Holtzman, C.W., Ryan, A.T., Shapiro, D.I., MacDonald, A.N., Goulding, S.M., Brasfield, J.L., Walker, E.F. 2013. The development of psychotic disorders in adolescence: a potential role for hormones. Horm Behav 64(2): 411-9. Unger, C.A. 2017. Update on gender-affirming treatment for the transgender woman. Semin Reprod Med 35(5): 442-7. Van Goozen, S.H., Cohen-Kettenis, P.T., Gooren, L.J., Frijda, N.H., Van de Poll, N.E. 1995. Gender differences in behaviour: activating effects of cross-sex hormones. Psychoneuroendocrinology 20(4): 343-63. Webb, R., Safer, J.D. 2019. Transgender hormonal treatment. dlm. yen and jaffe’s reproductive endocrinology (Eighth Edition); 709-16. Weickert, T.W., Allen, K.M., Weickert, C.S. 2016. Potential role of oestrogen modulation in the treatment of neurocognitive deficits in schizophrenia. CNS drugs 30(2): 125-33. Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., T’Sjoen, G. 2012. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 9(10): 2641-51. Zitzmann, M., Nieschlag, E. 2001. Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol 144(3): 183-97. Zucker, K.J. 1985. Cross-gender-identified children. In: Steiner B.W. (eds) Gender Dysphoria. Perspectives in Sexuality (Behavior, Research, and Therapy). Springer, Boston, MA; 75-174.